Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-02-06 @ 12:26 AM
Study NCT ID:
NCT03801434
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2019-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Sponsor:
William Shomali
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-09
First Submit QC Date:
None
Study First Post Date:
2019-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-20
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED